Simmons Bank’s Biogen BIIB Stock Holding History

Simmons Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,680	Closed	-$1.27M	–	374
2021 Q2	$1.27M	Buy	3,680 +173	+5%	+$52.4K	0.09%	187
2021 Q1	$981K	Buy	3,507 +114	+3%	+$30.7K	0.07%	210
2020 Q4	$830K	Sell	3,393 -458	-12%	-$118K	0.07%	223
2020 Q3	$1.09M	Sell	3,851 -1,287	-25%	-$359K	0.09%	175
2020 Q2	$1.38M	Sell	5,138 -581	-10%	-$175K	0.11%	157
2020 Q1	$1.81M	Buy	5,719 +1,377	+32%	+$418K	0.16%	117
2019 Q4	$1.29M	Buy	4,342 +364	+9%	+$101K	0.12%	154
2019 Q3	$926K	Buy	+3,978	New	+$926K	0.09%	191
2019 Q1	–	Sell	-761	Closed	-$229K	–	372
2018 Q4	$229K	Sell	761 -10	-1%	-$3.19K	0.03%	329
2018 Q3	$273K	Buy	+771	New	+$265K	0.03%	334
2018 Q1	–	Sell	-658	Closed	-$210K	–	350
2017 Q4	$210K	Sell	658 -10	-1%	-$3.21K	0.02%	293
2017 Q3	$209K	Buy	+668	New	+$198K	0.02%	303
2016 Q4	–	Sell	-640	Closed	-$200K	–	297
2016 Q3	$200K	Buy	+640	New	+$190K	0.02%	278

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Simmons Bank's BIIB Position: Q3 2021 in Review

Simmons Bank sold out of Biogen (BIIB) in Q3 2021, closing a stake of 3,680 shares — an estimated $1.27M sold.

Simmons Bank first reported a position in BIIB in Q3 2016 and held it in 13 quarters. The position peaked at $1.81M in Q1 2020. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Simmons Bank reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
Simmons Bank sold 3,680 Biogen shares in Q3 2021, an estimated $1.27M.
Simmons Bank first reported a position in Biogen in Q3 2016 and held it in 13 quarters.
Simmons Bank's Biogen position peaked at $1.81M in Q1 2020.
1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Simmons Bank's 13F filing for Q3 2021, filed 26 Oct 2021.